Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 · New England Journal of Medicine · 3,006 citations
https://doi.org/10.1056/nejm200011303432202
R
Ravinder N. Maini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
341
Papers
40.4K
Citations
85
h-index
206
i10-index
Ravinder N. Maini is an academic researcher from Midwestern University. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Monoclonal and Polyclonal Antibodies Research & Systemic Lupus Erythematosus Research. The author has an h-index of 85, co-authored 290 publications.
Papers by this author
worksROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 · Annual Review of Immunology · 2,518 citations
https://doi.org/10.1146/annurev.immunol.14.1.397
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 · The Lancet · 2,342 citations
https://doi.org/10.1016/s0140-6736(99)05246-0
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
2001 · Annual Review of Immunology · 1,240 citations
https://doi.org/10.1146/annurev.immunol.19.1.163
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
1993 · Arthritis & Rheumatism · 1,035 citations
https://doi.org/10.1002/art.1780361206
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
2005 · Arthritis & Rheumatism · 455 citations
https://doi.org/10.1002/art.20982
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat